Le Lézard
Classified in: Business
Subjects: EARNINGS, Conference Call, Webcast, Advisory

Mednow to Host Quarterly Conference Call on Tuesday November 29, 2022, at 8:30am EST on its Fourth-Quarter 2022 Financial Results


Mednow Inc. ("Mednow'' or the "Company") (TSXV:MNOW), Canada's on-demand virtual pharmacy, is pleased to announce the Company will be hosting its quarterly conference call on Tuesday November 29, 2022 at 8:30am EST. The conference call will cover its fourth-quarter 2022 financial results.

During the call, the Mednow team will provide an update on Mednow's expansion, recent strategic partnerships, milestones, M&A activities, and fourth-quarter 2022 financial results. Please use one of the two dial-in numbers provided below five minutes before the scheduled start time and specify the Mednow call.

Conference Call details:
Canada/USA Toll-free: 1-800-319-4610
International Toll: 1-604-638-5340

Reported results will be available on the Company's website at: https://investors.mednow.ca/financial-reports/

About Mednow Inc.

Mednow (TSXV: MNOW) (OTCQX:MDNWF) is a healthcare technology company offering virtual access with a high-standard of care. Designed with accessibility and quality of care in mind, Mednow provides virtual pharmacy and telemedicine services as well as doctor home visits through an interdisciplinary approach to healthcare that is focused on the patient experience. Mednow's services include free at-home medication delivery, virtual consultations with clinicians, a user-friendly interface to easily fill, transfer, and refill prescriptions, access to healthcare professionals through an intuitive chat experience and the specialized PillSmarttm system that packages prescriptions in easy to use daily dose packs, each labelled with the date and time of the next dose.

To learn more, follow Mednow on Facebook, Twitter, LinkedIn, and Instagram, or visit our website at www.mednow.ca/.

Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.


These press releases may also interest you

at 14:56
Egret Therapeutics, a clinical-stage biotechnology company focused on developing transformative therapies for neurological conditions, today announced that the U.S. Food and Drug Administration (FDA) has cleared its Investigational New Drug (IND)...

at 13:00
Third Tier Wealth Management, offering financial planning & investment management, today announced that they have entered into an agreement to work with Buckingham Strategic Partners (BSP), a national financial services firm with their main office in...

at 11:45
WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of ESS Tech Inc. between August 11, 2022 and December 7, 2022, both dates inclusive (the "Class Period"), of the important March 13, 2023 lead plaintiff...

at 11:00
Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Silvergate Capital Corporation ("Silvergate" or the "Company") and reminds investors of the February 6, 2023 deadline to seek the role of lead...

at 11:00
Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Super Micro Computer Inc.  ("Super Micro" or the "Company") ....

at 09:00
Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against NewAge, Inc. ("NewAge" or the "Company") and reminds investors of the February 6, 2023 deadline to seek the role of lead plaintiff in a federal...



News published on 25 november 2022 at 07:05 and distributed by: